Brosch, Katharina http://orcid.org/0000-0002-0526-8095
Stein, Frederike http://orcid.org/0000-0002-5052-6022
Schmitt, Simon
Pfarr, Julia-Katharina
Ringwald, Kai G.
Thomas-Odenthal, Florian
Meller, Tina
Steinsträter, Olaf
Waltemate, Lena http://orcid.org/0000-0001-7331-0534
Lemke, Hannah
Meinert, Susanne
Winter, Alexandra http://orcid.org/0000-0003-3759-1425
Breuer, Fabian
Thiel, Katharina
Grotegerd, Dominik
Hahn, Tim http://orcid.org/0000-0001-6541-3795
Jansen, Andreas
Dannlowski, Udo http://orcid.org/0000-0001-7117-2908
Krug, Axel
Nenadić, Igor
Kircher, Tilo
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HA7070/2-2, JA1890/7-1, JA1890/7-2, DA 1151/5-1, DA 1151/5-2, DA 1151/6-1, KR 3822/5-1, KR 3822/7-2, KI 588/14-1, KI 588/14-2, KI 588/15-1, KI 588/17-1)
Article History
Received: 15 December 2021
Revised: 22 June 2022
Accepted: 27 June 2022
First Online: 15 July 2022
COMPETING INTERESTS
: Biomedical financial interests or potential conflicts of interest: Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, and neuraxpharm. All other authors declare no competing interests.
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.